SCYNEXIS INC

Scynexis (SCYX) struggles amid thin liquidity, 17.8 % decline, and a price below its 200‑day SMA—investors need to watch regulatory moves and new partnerships for a turnaround.

Scynexis (SCYX) slides 16% on a weak market: is a strategic reset possible? Discover why this niche biotech may still hold upside potential.

Scynexis (SCYX) slips 0.27% to $3.80 as investors weigh a 16.8% YTD decline and 52‑week low—see detailed volume, cap, and peer comparisons.